TNF and inflammatory bowel disease: Veres et al. observed a 3.7% rate of herpes zoster in adolescents with IBD using IFX [60], comparable to our study’s 4.8% incidence, suggesting consistency with the existing literature on herpes zoster risk in pediatric IBD patients receiving anti-TNF therapy.